Opioid Use in Knee Arthroplasty After Receiving Intravenous Acetaminophen

作者
Jennifer S. Kelly,Yekaterina Opsha,Jennifer Costello,Daryl S. Schiller,Eric T. Hola
出处
期刊:Pharmacotherapy [Wiley]
卷期号:34 (S1): 22S-26S 被引量:40
标识
DOI:10.1002/phar.1518
摘要

BACKGROUND: Intravenous (IV) acetaminophen may be an effective component of multimodal postoperative pain management. The primary objective of this study was to evaluate the impact of IV acetaminophen on total opioid use in postoperative patients. The secondary objective was to evaluate the effect of IV acetaminophen on hospital length of stay. METHODS: This retrospective, case-control study evaluated the impact of IV acetaminophen on total opioid use in surgical patients. Patients were included if they received at least one perioperative dose of IV acetaminophen and underwent a surgical knee procedure. Controls were matched and randomly selected based on procedure type, age, and severity of illness. Postoperative opioids were converted into oral morphine equivalents, and overall use was compared between groups. RESULTS: One hundred patients were enrolled, with 25 patients receiving IV acetaminophen and 75 matched controls. A total of 135 mg versus 112.5 mg oral morphine equivalents were used in the IV acetaminophen group and control group, respectively (p=0.987). There were 45 mg/day oral morphine equivalents used in the IV acetaminophen group versus 37.5 mg in the control group (p=0.845). The median hospital length of stay in both groups was 3 days (p=0.799). CONCLUSION: IV acetaminophen did not significantly decrease postoperative opioid use in patients who underwent surgical knee procedures. In addition, there was a nonsignificant trend toward increased opioid use in the IV acetaminophen group. There was no significant difference in hospital length of stay between the IV acetaminophen group and the control group. These findings require further study in larger patient populations and in other orthopedic procedures that typically require longer hospital stays.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
包凡之完成签到,获得积分10
刚刚
Akim应助明月采纳,获得10
刚刚
刚刚
昀朵有点甜完成签到,获得积分10
1秒前
wendy_1006完成签到 ,获得积分10
1秒前
皓月当空完成签到,获得积分10
1秒前
沫崽完成签到 ,获得积分10
2秒前
xdx发布了新的文献求助10
2秒前
zhabgyucheng完成签到,获得积分10
3秒前
Enyu完成签到 ,获得积分10
3秒前
矜持完成签到,获得积分10
3秒前
李健应助科研通管家采纳,获得10
3秒前
3秒前
mxm完成签到,获得积分10
4秒前
斯文败类应助科研通管家采纳,获得10
4秒前
lZzz应助科研通管家采纳,获得10
4秒前
4秒前
大个应助科研通管家采纳,获得10
4秒前
脑洞疼应助科研通管家采纳,获得10
4秒前
cdercder应助科研通管家采纳,获得10
4秒前
5秒前
波力海苔完成签到 ,获得积分10
5秒前
sagitar应助科研通管家采纳,获得10
5秒前
Cheng9nine完成签到,获得积分10
5秒前
sagitar应助科研通管家采纳,获得10
5秒前
sagitar应助科研通管家采纳,获得10
5秒前
zcw完成签到,获得积分10
5秒前
sagitar应助科研通管家采纳,获得10
5秒前
那时花开应助科研通管家采纳,获得10
5秒前
6秒前
天天快乐应助科研通管家采纳,获得10
6秒前
爆米花应助科研通管家采纳,获得10
6秒前
英俊的铭应助科研通管家采纳,获得10
6秒前
大模型应助科研通管家采纳,获得10
6秒前
科目三应助科研通管家采纳,获得10
6秒前
haralee完成签到 ,获得积分10
7秒前
CasterL完成签到,获得积分10
8秒前
8秒前
9秒前
汉堡包应助烂漫的从寒采纳,获得10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Principles of town planning: translating concepts to applications 1000
Management and the Arts 510
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
核安全综合知识2024版 500
Photothermal Science and Techniques 500
Digital Displacement Hydrostatic Transmission for Rotorcraft and Distributed Propulsion 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7711621
求助须知:如何正确求助?哪些是违规求助? 9267867
关于积分的说明 20068668
捐赠科研通 7288220
什么是DOI,文献DOI怎么找? 3297286
关于科研通互助平台的介绍 2451805
邀请新用户注册赠送积分活动 2304320